The Evolution of HCP Engagement

By Impiricus
November 1, 2022

Consequences and Opportunities for Biopharma Brand Strategies and Tactics

TheEvolutionofHCPsEngagement-1

READ OUR CONTENT

News And Insights

Press

New York Stock Exchange Spotlights Impiricus for Unprecedented Impact for Physicians and Pharma

NEW YORK, NY — December 22, 2025 — Impiricus, the leading AI-powered...

Press

Nasdaq Celebrates Impiricus for 30,000% Growth and AI Innovation in Healthcare

NEW YORK, NY — On December 15, 2025, Impiricus, a leader in...

Press

Mike Gelber, Chief Product Officer at Impiricus, Named to MM+M’s 40 Under 40 List

NEW YORK, NY – December 4, 2025 – MM+M has announced its...